PROSPERiA SALUD, S.A. DE C.V.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
PROSPERiA SALUD, S.A. DE C.V. - overview
Established
2020
Location
Mexico City, -, Mexico
Primary Industry
Healthcare
About
Based in Mexico, and founded in 2020, Properia operates as a technology-based healthcare company that operates for early detection and treatment of chronic diseases. The company was Co-founded by its CEO Cristina Campero and others. In July 2022, PROSPERiA raised USD 2 million in seed funding led by Cardo Health AB. The firm offers artificial intelligence-based medical technology solutions which include early detection of cardiometabolic diseases and related visual complications.
It uses risk assessment calculators, retinal image analysis, and a non-invasive fundus camera. The risk assessment calculator offered by the firm could be filled out online and helps in the determination of diseases like diabetes, hypertension, or an ophthalmological condition. The firm also provides an eye health assessment.
Current Investors
Cardo Health AB, MassChallenge
Primary Industry
Healthcare
Sub Industries
Diagnostic, Medical & Imaging Laboratories, Healthcare IT, Diagnostic Equipment, Medical Software
Verticals
Artificial Intelligence, Cloud Computing, HealthTech
Company Stage
Angel & Seed
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.